Table 4 Cox univariate analysis of progression-free survival including baseline clinical and treatment criteria
Variables | N | HR | 95 CI | p-value | |
|---|---|---|---|---|---|
Age | Continuous | 68 | 1.02 | 0.97–1.06 | 0.45 |
BMI | Continuous | 62 | 1.04 | 0.97–1.10 | 0.26 |
Localization | Cervix vs endometrium | 68 | 1.92 | 0.56–6.69 | 0.3 |
Surgical margins | Pos vs neg | 58 | 2.5 | 0.77–7.69 | 0.13 |
pN | Pos vs neg | 66 | 2.32 | 0.95–5.88 | 0.06 |
LVI | Pos vs neg | 53 | 2.17 | 0.70–6.67 | 0.18 |
FIGO stage | I-II vs III-IV | 64 | 0.53 | 0.22–1.32 | 0.17 |
Chemotherapy | No vs yes | 68 | 0.63 | 0.21–1.32 | 0.17 |
Radiotherapy | No vs yes | 68 | 3.07 | 1.26–7.48 | 0.014 |
Brachytherapy | No vs yes | 65 | 3.08 | 1.21–7.86 | 0.019 |